About 50 results
Open links in new tab
  1. New Parkinson's Disease Gene Discovered - Medscape

    Jul 17, 2024 · A new gene for early-onset Parkinson's disease has been identified, a discovery that experts believe will have important clinical implications in the not-too-distant future.

  2. Examining the Fingernails When Evaluating Presenting Symptoms …

    Nov 23, 2009 · If the lunula is absent, consider anemia or malnutrition (Figure 16). A pyramidal lunula might indicate excessive manicure or trauma (Figure 17). A pale blue lunula suggests …

  3. Talking About Sex Remains the Elephant in the Room for GPs

    Sep 22, 2025 · This pyramidal framework begins with obtaining the patient’s permission to raise sexual issues, builds awareness of knowledge gaps, moves to “specific suggestions” based on …

  4. Progressive Supranuclear Palsy and Corticobasal Degeneration

    This article discusses the similarities and differences between these disorders in clinical manifestations, neuroimaging and neuropathology and provides a perspective on possible …

  5. Cytisinicline Improves Quit Rates in Smokers - Medscape

    Sep 25, 2025 · Cytisinicline significantly increases quit rates in smokers with or without COPD while being safe and well tolerated.

  6. Modern Specialist Training: Brainchild of a Cocaine Addict

    Mar 24, 2025 · The pyramidal structure of his training program, the competitive selection of exceptional residents, and their heavy workload all helped to conceal Halsted’s drug …

  7. Diabetes and Liver: Drives Disease and Worsens Outcomes

    Sep 22, 2025 · Dr Priya Jaisinghani discusses how diabetes drives liver disease progression and worsens clinical outcomes.

  8. Our Diet Is Our Destiny - Medscape

    Sep 10, 2025 · Dr Wilkoff explains that diet, not lack of exercise or sleep, is responsible for high rates of obesity.

  9. Psilocybin Safe, Effective for TRD: Phase 3 Data - Medscape

    Jun 24, 2025 · A single dose of a synthetic form of psilocybin is safe and clinically meaningful in reducing treatment-resistant depression, topline results from a phase 3 trial suggest.

  10. Oral GLP-1 Will ‘Change and Enhance’ Obesity Treatment

    Sep 24, 2025 · The FDA will decide on whether to approve the first oral formulation of a GLP-1 (once-daily semaglutide 25 mg) for chronic weight management by the end of the year.